1. Home
Press Release

Siemens and MIT Advance US manufacturing

2025. gada 27. maijs
Cambridge, MA

The MIT Initiative for New Manufacturing (INM) drives AI innovation in production technologies

Siemens to invest $1.5M in MIT-led manufacturing research over three years to scale adaptive, resilient production in the U.S. 

Siemens announced today a new collaboration with the Massachusetts Institute of Technology (MIT) as a Founding Member of the MIT Initiative for New Manufacturing (INM). This collaboration will focus on next-generation production technologies, AI-powered manufacturing systems, and workforce development to rebuild industrial strength in the United States in a more resilient, sustainable, and competitive way. 

“Adaptive production is more than just a vision – it's a necessity”, said Peter Koerte, Member of the Managing Board, Chief Technology Officer and Chief Strategy Officer of Siemens. “As American industry faces growing challenges, we need technologies that can respond in real time. This collaboration with MIT brings together the best of research and real-world implementation. Together, we’re laying the foundation for a new era of resilient, AI-powered manufacturing – built to adapt, built to last.

Following decades of industrial offshoring, manufacturing is once again becoming a strategic capability in the United States – vital for economic resilience, national security, and innovation. Rebuilding this capability requires new partnerships, platforms, and skilled people. Therefore, Siemens will work in collaboration with MIT to build new programs and opportunities with industry, government, and others, engaging students and faculty with expertise from across MIT.

Key Highlights

Over the next three years, Siemens will contribute $1.5 million to fund research, innovation, and training through INM. The initiative will serve as a national testbed and knowledge hub for U.S. reindustrialization, supporting a broad spectrum of organizations – from startups to major industrial players.

Industry Council Participation: Siemens will join INM’s Industry Council, working alongside industry leaders to define manufacturing research agendas and strategic goals with a focus on next-generation production technologies, AI-powered manufacturing systems, and workforce development.

Engagement in MIT Research: Siemens will actively participate in MIT’s flagship research projects – from AI in manufacturing to new system architectures and supply chain modeling – contributing challenges, data, and industrial use cases.

AI-Powered Manufacturing: Together, Siemens and MIT will research next-generation AI-driven manufacturing solutions through workshops, working groups, seed research projects, case studies, and the mutual sharing of tools and techniques. 

Education and Training Programs: Siemens will collaborate on INM’s new executive and engineering education initiatives, including online courses and AI-driven coaching tools. These programs will also be offered to Siemens employees to enhance their skills and expertise. 

Building on a Long-Standing Collaboration

The collaboration between Siemens and MIT dates back to 2008. Since then, Siemens has sponsored 80 research projects and participated in two publicly-funded initiatives – Defense Advanced Research Projects Agency (DARPA)’s Symbiotic Design for Cyber Physical Systems (SDCPS) and Department of Energy (DOE)’s Integrated Electrochemical Processes for CO2 Capture and Conversion to Commodity Chemicals.

Siemens AG (Berlin and Munich) is a leading technology company focused on industry, infrastructure, mobility, and healthcare. The company’s purpose is to create technology to transform the everyday, for everyone. By combining the real and the digital worlds, Siemens empowers customers to accelerate their digital and sustainability transformations, making factories more efficient, cities more livable, and transportation more sustainable. A leader in industrial AI, Siemens leverages its deep domain know-how to apply AI – including generative AI – to real-world applications, making AI accessible and impactful for customers across diverse industries. Siemens also owns a majority stake in the publicly listed company Siemens Healthineers, a leading global medical technology provider pioneering breakthroughs in healthcare. For everyone. Everywhere. Sustainably.

In fiscal 2024, which ended on September 30, 2024, the Siemens Group generated revenue of €75.9 billion and net income of €9.0 billion. As of September 30, 2024, the company employed around 312,000 people worldwide on the basis of continuing operations. Further information is available on the Internet at www.siemens.com

This document contains statements related to our future business and financial performance and future events or developments involving Siemens that may constitute forward-looking statements. These statements may be identified by words such as “expect,” “look forward to,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “estimate,” “will,” “project” or words of similar meaning. We may also make forward looking statements in other reports, in prospectuses, in presentations, in material delivered to shareholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements are based on the current expectations and certain assumptions of Siemens’ management, of which many are beyond Siemens’ control. These are subject to a number of risks, uncertainties and factors, including, but not limited to those described in disclosures, in particular in the chapter Report on expected developments and associated material opportunities and risks in the Combined Management Report of the Siemens Report (siemens.com/siemensreport), and in the Interim Group Management Report of the Half-year Financial Report (provided that it is already available for the current reporting year), which should be read in conjunction with the Combined Management Report. Should one or more of these risks or uncertainties materialize, should decisions, assessments or requirements of regulatory authorities deviate from our expectations, should events of force majeure, such as pandemics, unrest or acts of war, occur or should underlying expectations including future events occur at a later date or not at all or assumptions prove incorrect, actual results, performance or achievements of Siemens may (negatively or positively) vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Siemens neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated. This document includes – in the applicable financial reporting framework not clearly defined – supplemental financial measures that are or may be alternative performance measures (non-GAAP-measures). These supplemental financial measures should not be viewed in isolation or as alternatives to measures of Siemens’ net assets and financial positions or results of operations as presented in accordance with the applicable financial reporting framework in its Consolidated Financial Statements. Other companies that report or describe similarly titled alternative performance measures may calculate them differently. 

Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

Contacts for Press

Siemens USA
Christine Whitman 
Phone: + 1- 202-316-2347 
E-mail: christine.whitman@siemens.com

Siemens AG
Franziska Isnard
Phone: +49 162 180 2712  
E-mail: franziska.isnard@siemens.com